Testing version — LOERadar is in active testing. Features and data may change.
XARELTO (RIVAROXABAN) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
XARELTO
NDANot in Orange Book
RIVAROXABAN | N202439 | JANSSEN PHARMS
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (4)
Sort:
#001 — 10MG
▴
TABLET;ORAL | Approved: Nov. 4, 2011
No patent or exclusivity listings for this strength.